Article title: Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)
Authors: Nakamura Ichiro, Maegawa Hiroshi, Tobe Kazuyuki, Uno Satoshi.
Journal: EXPERT OPINION ON PHARMACOTHERAPY
Bibliometrics: Volume 22, Number 03, pages 373-387
DOI: https://doi.org/10.1080/14656566.2020.1817388
When this article was first published in an issue, there was an error in which has been now corrected as below in the original article.
Abbreviation: ADRs, adverse drug reactions. Note: No. of patients (%) is shown.